2019 Looking to the Future ForumOctober 10, 2019
Thursday 10 October, 10:30 am – 2:00 pm
*Tea and coffee available from 10:30am with an 11:00am start time.
What does the future look like? Join us and hear from leaders in the field about gene and cell therapy and the latest in artificial intelligence and new technology in eye research.
Broken into two panels, the team at the Centre for Eye Research Australia (CERA) will discuss some of the ground breaking research in the exciting and promising areas of stem cells and the use of artificial intelligence in better treating and diagnosing eye disease.
All are welcome at our community events, aimed at a general audience. Come for one or both panels. A light lunch will be provided in between sessions.
Panel 1 – Gene therapy demystified
Managing Director Professor Keith Martin
Professor Keith Martin is Managing Director of the Centre for Eye Research Australia and Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne. He is working to develop new treatments for eye disease using stem cells, gene therapy and other techniques.
Dr Thomas Edwards
Dr Thomas Edwards’ research looks at the potential of gene therapy to cure inherited retinal diseases. His research aims to establish the infrastructure and knowledge base necessary to develop treatments that may halt or partially reverse some inherited causes of blindness.
Lisa Kearns is a Research Orthoptist and Associate Genetic Counsellor co-ordinating research studies into inherited eye diseases. These studies investigate their genetic cause and the use of stem cells to better understand eye disease in the hope of developing new treatments.
Panel 2 – Everything you need to know about AI and new technology
Deputy Director Associate Professor Peter van Wijngaarden
Associate Professor Peter van Wijngaarden’s research focuses on three key areas: novel imaging technologies to detect early markers of eye and central nervous system diseases, such as Alzheimer’s disease; understanding the role played by support cells in the optic nerve and the implications that this has for the management of diseases of the optic nerve; and understanding the causes of diabetic retinopathy and identifying new avenues for treatment.
Associate Professor Penny Allen
Associate Professor Penny Allen leads the bionic eye research at CERA. Her team has developed a next-generation bionic eye implant which is now in trial and has been implanted in four patients. It offers the patients the possibility of using the device at home and creates a sense of sight.
Dr Jane Scheetz
Dr Jane Scheetz is an orthoptist and post-doctoral research fellow. Her research focuses on the development and clinical implementation of artificial intelligence systems which can accurately detect common blinding eye diseases such as diabetic retinopathy, glaucoma, age-related macular degeneration and cataract.
Phone: Morgan – 03 9929 8426
250-290 Spring Street, East Melbourne